Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ILMN | 8-K | neutral | 3/10 | Illumina issued $300M of 4.950% notes due 2029 via an underwritten public offering. The net proceeds, together with cash | Aug 12, 2026 |
| CTTH | 8-K | bullish | 4/10 | CTT Pharmaceutical Holdings received a continuation-in-part (CIP) patent approval from the USPTO for its micelle deliver | Aug 12, 2026 |
| FUSE | 8-K | neutral | 5/10 | Fusemachines entered into a strategic commercial agreement with Qintess, a Brazilian technology company, that includes a | Aug 12, 2026 |
| UNCY | 8-K | mixed | 6/10 | Unicycive Therapeutics reported Q2 2026 results with a net loss of $(1.7) million ($(0.06)/share), significantly narrowe | Aug 12, 2026 |
| UPS | 8-K | neutral | 3/10 | UPS issued $1 billion in 4.850% Senior Notes due 2031 via an underwriting agreement dated August 10, 2026. Of the total, | Aug 12, 2026 |
| ABUS | 8-K | bullish | 7/10 | Arbutus Biopharma reported Q2 2026 results with a net loss of $5.1M ($-0.03 EPS) vs net income of $2.5M ($0.01 EPS) in Q | Aug 12, 2026 |
| MIST | 8-K | bearish | 6/10 | Milestone Pharmaceuticals reported Q2 2026 results with product revenue of $0.6M, up from zero a year ago, but net loss | Aug 12, 2026 |
| XLO | 8-K | bullish | 7/10 | Xilio Therapeutics reported Q2 2026 results with collaboration revenue of $18.7M (up 131% YoY) and a net loss of $6.4M ( | Aug 12, 2026 |
| ALT | 8-K | neutral | 5/10 | Altimmune reported Q2 2026 results with a net loss of $0.12 per share, beating consensus estimates of -$0.13 by 7.7%. Th | Aug 12, 2026 |
| LOCL | 8-K | mixed | 5/10 | Local Bounti reported Q2 2026 revenue of $13.9M (+14% YoY) and a GAAP net loss of -$19.8M, with adjusted EBITDA loss imp | Aug 12, 2026 |
| CAPS | 8-K | bearish | 8/10 | Capstone Holding Corp. filed an 8-K disclosing that its previously issued financial statements for Q2 and Q3 2025, and c | Aug 12, 2026 |
| TRMB | 8-K | mixed | 6/10 | Trimble reported Q2 2026 revenue of $972.0M (+11% YoY), beating consensus of $952.1M, and non-GAAP EPS of $0.86, beating | Aug 12, 2026 |
| SPMC | 8-K | neutral | 4/10 | Sound Point Meridian Capital, Inc. reported Q1 fiscal 2026 results with GAAP net income of $17.5M ($0.83/share) and decl | Aug 12, 2026 |
| PLX | 8-K | neutral | 5/10 | Protalix reported Q2 2026 revenue of $19.9M, beating the $12.9M consensus, and EPS of $0.05, beating the $-0.01 consensu | Aug 12, 2026 |
| PFGC | 8-K | neutral | 5/10 | Performance Food Group reported Q4 FY2026 results with net sales of $18.0B (+6.4% YoY) and GAAP diluted EPS of $1.03 (+2 | Aug 12, 2026 |
| AMCR | 8-K | bullish | 6/10 | Amcor reported Q4 FY2026 adjusted diluted EPS of $1.23, a 3.2% beat vs. the $1.19 consensus, on revenue of $6.398B (abov | Aug 12, 2026 |
| ANNX | 8-K | bullish | 6/10 | Annexon reported Q2 2026 results with a net loss of $0.28/share, slightly wider than the prior year's $0.34/share loss, | Aug 12, 2026 |
| TECH | 8-K | bullish | 7/10 | Bio-Techne reported Q4 FY2026 results with organic revenue growth of 3% (reported +1% to $321.2M), GAAP EPS of $0.35 vs | Aug 12, 2026 |
| LQDA | 8-K | bullish | 6/10 | Liquidia reported Q2 2026 net product sales of $170.4M (+31% QoQ), net income of $74.7M ($0.74 diluted EPS), and adjuste | Aug 12, 2026 |
| TE | 8-K | mixed | 6/10 | T1 Energy reported Q2 2026 results that were largely in line with the preliminary numbers released two weeks prior, with | Aug 12, 2026 |
| KTB | 8-K | bullish | 6/10 | Kontoor Brands reported Q2 2026 adjusted EPS of $1.06, a 13% YoY increase and a 2.1% beat vs consensus, on revenue of $5 | Aug 12, 2026 |
| ONAR | 8-K | neutral | 4/10 | ONAR Holding Corp filed an 8-K disclosing Amendment No. 2 to its non-binding letter of intent to acquire Advertise Purpl | Aug 11, 2026 |
| LEE | 8-K | neutral | 3/10 | Lee Enterprises filed an 8-K disclosing that its Executive Compensation Committee approved one-time transition equity aw | Aug 11, 2026 |
| TNGX | 8-K | bearish | 6/10 | Tango Therapeutics upsized its at-the-market (ATM) equity offering program from $100M to $400M, terminating the prior $1 | Aug 11, 2026 |
| NFG | 8-K | neutral | 2/10 | National Fuel Gas filed an 8-K to submit a legal opinion from Scarinci & Hollenbeck, LLC as an exhibit to its existing S | Aug 11, 2026 |
| GOAI | 8-K | neutral | 4/10 | Eva Live's subsidiary Eva Defense signed a $1.2 million, 12-month development agreement with Boumarang Inc. to design an | Aug 11, 2026 |
| WAMFF | 8-K | mixed | 5/10 | Alaska Silver Corp. announced a C$7.6 million (approx. US$5.5 million) PIPE financing, issuing 13.85 million units at C$ | Aug 11, 2026 |
| RBC | 8-K | neutral | 3/10 | RBC Bearings acquired the business assets of PSC Couplings, LLC, a disc coupling manufacturer, for $24.2 million in cash | Aug 11, 2026 |
| BRLL | 8-K | bearish | 8/10 | Barrel Energy Inc. closed a distressed financing package with Coventry Enterprises, LLC on August 5, 2026, consisting of | Aug 11, 2026 |
| ACHV | 8-K | neutral | 5/10 | Achieve Life Sciences reported Q2 2026 financial results, highlighting a net loss of $74.8M for the quarter (including a | Aug 11, 2026 |